Clinical Trials Logo

Opioid Use clinical trials

View clinical trials related to Opioid Use.

Filter by:

NCT ID: NCT05930184 Recruiting - Opioid Use Clinical Trials

Laparoscopic Guided Peri-wound Transversus Abdominis Plane Block With Bupivacaine Versus Local Wound Infiltration on Post-op Opioid Use in Laparoscopic Sleeve Gastrectomy

Start date: April 29, 2023
Phase: Phase 2/Phase 3
Study type: Interventional

The goal of this randomized controlled trial is to compare laparoscopic guided peri-wound Transversus Abdominis Plane Block and bupivacaine versus local wound infiltration effect on reducing post-op opioid use in Laparoscopic Sleeve gastrectomy. The main questions it aims to answer are: • Can laparoscopic guided peri-wound Transversus Abdominis Plane Block reduced post operative morphine usage when comparing with local wound port site infiltration. Participants will be randomize into 2 group - peri-wound Transversus Abdominis Plane Block - local wound port site infiltration

NCT ID: NCT05908097 Recruiting - Opioid Use Clinical Trials

Enhancing Prospective Thinking in Early Recovery (PARK)

PARK
Start date: April 4, 2023
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to demonstrate the commercial potential for a novel virtual reality (VR) intervention in preparation for Phase II development. This clinical trial will test the VR intervention for efficacy in reducing opioid use, increasing abstinence, and other self-reported and behavioral focus on future outcomes in individuals in early recovery from opioid use disorder. - Will the VR group, compared to the control group, have a lower number of opioid use days? - Will the VR group, compared to the control group, have longer periods of abstinence at the 30-day follow-up? - Will the VR group, compared to the control group, have significantly increased opioid abstinence rates? - Will the VR group, compared to baseline and the control group, show increased future self-identification post-VR intervention? - Will the VR group, compared to baseline and the control group, show increased future orientation post-VR intervention? - Will the VR group, compared to baseline and the control group, show an increased preference for delayed rewards in a laboratory delay discounting task post-VR intervention? - Will the VR group, compared to baseline and the control group, exceed in behavioral effects (i.e., future self-identification, future orientation, and increased preference for delayed rewards) at the 30-day follow-up? Researchers will compare the VR test group and the control group to see if there are differences in the results for the questions outlined above.

NCT ID: NCT05905419 Recruiting - Chronic Pain Clinical Trials

Neuroimaging of Opioid Phase (OPAL)

OPAL
Start date: June 1, 2023
Phase: N/A
Study type: Interventional

The purpose of this study is to compare activity in the brains of female adults with chronic pain and/or opioid use, and healthy female adults that may help to develop new and targeted treatments for adults with chronic pain and alternatives to opioid therapy.

NCT ID: NCT05877157 Recruiting - Quality of Life Clinical Trials

Pain AND Opioids After Surgery

PANDOS
Start date: September 25, 2023
Phase:
Study type: Observational

The aim of this study is to document the perioperative opioid use and its safety in the UK and countries in Europe and to describe its association with surgical complications, persistent pain and quality of life. In an international, prospective, observational cohort study, data about the perioperative pain management will be collected in all eligible hospitalised adult patients who undergo surgery in a designated "study week" in as many hospitals as possible in Europe. Baseline data will be collected, and participants followed up at one week, and at three and twelve months post-operatively. The primary outcome will be opioid use at three months after surgery. Secondary outcomes will include opioid use during the preoperative month (preoperative use), during surgery and up to one week after surgery (or discharge, whichever is earlier), and up to the end of the postoperative year. Additional secondary outcomes are the incidence of preoperative pain, persistent pain with/without the presence of neuropathic components, quality of life and surgical complications. The potential association between opioid use and pain outcomes will be investigated. This study could help to develop strategies to improve quality of care, through pain management, for patients undergoing surgery.

NCT ID: NCT05875207 Recruiting - Chronic Pain Clinical Trials

Physical Therapy Integrated With Mindfulness for Patients With Chronic Pain and Opioid Treatment

PT-IN-MIND
Start date: August 14, 2023
Phase: N/A
Study type: Interventional

This study will use multiple methods to assess the feasibility of conducting a fully powered multisite clinical trial to test the effectiveness of integrating mindfulness-based interventions into physical therapy for patients with chronic musculoskeletal pain and long-term opioid treatment. First, researchers will develop a manual for training physical therapists to provide mindfulness-based interventions to patients with chronic musculoskeletal pain and long-term opioid treatment. Next, the researchers will evaluate the competency of physical therapists to provided mindfulness-based interventions after being randomized to one of 3 different mindfulness training arms. Patients scheduled for physical therapy with the randomized physical therapists will be invited to enroll in the study. These patients will be asked to complete a variety of patient reported outcomes including self-reported average pain and the the amount of prescription opioid pain medication taken.

NCT ID: NCT05834478 Recruiting - Opioid Use Clinical Trials

Non-invasive Vagal Nerve Stimulation in Opioid Use Disorders UH3

VNS in OUD UH3
Start date: February 20, 2024
Phase: Phase 3
Study type: Interventional

This study is being done to answer the question: what is the effect of Vagal Nerve Stimulation (VNS) dosing on opioid withdrawal responses in individuals with a history of Opioid Use Disorders (OUDs)? Eligible participants will be in the study for one week in an inpatient research hospital stay, have an MRI scan, and have a follow-up call 1-3 months after their inpatient stay. Participants will complete several psychiatric questionnaires/interviews, physiological monitoring with several devices, brain imaging, and VNS testing.

NCT ID: NCT05828121 Recruiting - Chronic Pain Clinical Trials

POINT - Preventing an Opioid Epidemic in Norway: Focusing on Treatment of Chronic Pain

POINT
Start date: October 1, 2022
Phase: N/A
Study type: Interventional

The investigators do research on chronic pain treatment to minimize the risks associated with opioids.

NCT ID: NCT05818969 Recruiting - Anxiety Clinical Trials

Effects of Hypnosis Therapy on Outcomes in Total Knee Replacement

Start date: February 1, 2022
Phase: N/A
Study type: Interventional

The purpose of this study is to collect information to evaluate the role of the psychogenic component of pain induced by anxiety on postoperative outcomes in major orthopaedic surgery and to determine whether hypnosis therapy provided during the perioperative period will lead to decreased use of opioid therapy. Patients are randomly assigned to one of two treatment groups: (I) usual care, or; (II) hypnotherapy treatment. Patients have an equal chance of being assigned to one of the two groups.

NCT ID: NCT05805423 Recruiting - Opioid Use Clinical Trials

ENDOblock: Bilateral Superficial Cervical Blocks With Local Wound Infiltration in Thyroid Surgery

Start date: April 17, 2023
Phase: N/A
Study type: Interventional

This is a single center, prospective, double-blinded randomized controlled trial comparing the efficacy of bilateral superficial cervical plexus blocks (BSCPB) with local wound infiltration vs placebo with local wound infiltration in reducing thyroid surgery postoperative pain. Primary outcomes assessed are post operative pain, quality of life/recovery, post operative nausea/vomiting and opioid use.

NCT ID: NCT05804591 Recruiting - Obesity Clinical Trials

Pregabalin in the Obese Patients Undergoing Laparoscopic Sleeve Gastrectomy (LSG).

Start date: April 24, 2023
Phase: Phase 4
Study type: Interventional

The aim of this clinical trial is to assess preemptive oral pregabalin administration in the obese patients undergoing laparoscopic sleeve gastrectomy. The main aims of the study are to evaluate postoperative pain treatment and effect on the intraoperative hemodynamical stability. The participants will be divided into 2 groups: with or without preemptive pregabalin administration.